Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

520 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival data.
Bain S, Druyts E, Balijepalli C, Baxter CA, Currie CJ, Das R, Donnelly R, Khunti K, Langerman H, Leigh P, Siliman G, Thorlund K, Toor K, Vora J, Mills EJ. Bain S, et al. Diabetes Obes Metab. 2017 Mar;19(3):329-335. doi: 10.1111/dom.12821. Epub 2016 Dec 23. Diabetes Obes Metab. 2017. PMID: 27862902 Review.
Safety and adverse effects associated with GLP-1 analogues.
Stephens JW, Bain SC. Stephens JW, et al. Among authors: Bain SC. Expert Opin Drug Saf. 2007 Jul;6(4):417-22. doi: 10.1517/14740338.6.4.417. Expert Opin Drug Saf. 2007. PMID: 17688385 Review.
Clinical experience with exenatide in a routine secondary care diabetes clinic.
Natarajan B, Edavalath M, Davies J, Jenkins L, Marshall-Richards N, Evans D, Price DE, Bain SC, Stephens JW. Natarajan B, et al. Among authors: Bain SC. Prim Care Diabetes. 2010 Apr;4(1):57-60. doi: 10.1016/j.pcd.2009.11.001. Prim Care Diabetes. 2010. PMID: 20022310
Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus.
Stephens JW, Bodvarsdottir TB, Wareham K, Prior SL, Bracken RM, Lowe GD, Rumley A, Dunseath G, Luzio S, Deacon CF, Holst JJ, Bain SC. Stephens JW, et al. Among authors: Bain SC. Diabetes Res Clin Pract. 2011 Nov;94(2):199-206. doi: 10.1016/j.diabres.2011.07.014. Epub 2011 Aug 10. Diabetes Res Clin Pract. 2011. PMID: 21835486 Clinical Trial.
One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target.
Rosenstock J, Rodbard HW, Bain SC, D'Alessio D, Seufert J, Thomsen AB, Svendsen CB, DeVries JH; Liraglutide-Detemir Study Group. Rosenstock J, et al. Among authors: Bain SC. J Diabetes Complications. 2013 Sep-Oct;27(5):492-500. doi: 10.1016/j.jdiacomp.2013.04.008. Epub 2013 Jun 6. J Diabetes Complications. 2013. PMID: 23746555 Clinical Trial.
520 results
Jump to page
Feedback